Long intergenic non-protein coding RNA 1845 (LINC01845)

Long intergenic non-protein coding RNA 1845 (LINC01845) is a human long intergenic non-coding RNA (lincRNA) gene that transcribes a non-protein-coding RNA molecule[1][5]. LincRNAs are a subclass of long non-coding RNAs situated between protein-coding genes, typically lacking protein-coding potential but playing regulatory roles in gene expression[3]. LINC01845 has been identified through bioinformatic and machine learning analyses as one of several lncRNAs with significant differential expression in lung cancer, suggesting utility as a diagnostic biomarker in distinguishing lung cancer tissue from normal tissue[2]. However, there are no reports of LINC01845 acting as a direct therapeutic target (e.g., a receptor, enzyme, transporter), nor are there any known drugs or therapies that directly interact with it, nor associations with molecular mechanisms of action or safety considerations. Its main relevance currently appears as a candidate biomarker in oncology[2].

Other names

LINC01845